AbbVie’s Imbruvica victory at Federal Circuit adds to Humira successes

AbbVie’s Imbruvica victory at Federal Circuit adds to Humira successes

The company’s latest win means that its second highest selling drug will not face US competition for a decade

Unlock unlimited access to all IAM content